サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：細胞健康検査の世界市場
市場調査レポート
商品コード
1194012

細胞健康検査の世界市場

Cellular Health Testing
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.46円
細胞健康検査の世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の細胞健康検査の市場規模は、2022年の30億米ドルから2030年までに58億米ドルに達し、2022年～2030年にCAGRで8.6%の成長が予測されています。

当レポートでは、世界の細胞健康検査市場について調査分析し、市場の動向と促進要因、地域分析、競合情勢などを提供しています。

調査対象企業の例（全22社）：

  • Bio-Reference Laboratories, Inc.
  • Cell Science Systems Corp.
  • Cleveland Heartlab, Inc.
  • Dna Labs India
  • Genova Diagnostics
  • Immundiagnostik AG
  • Laboratory Corporation of America Holdings
  • Life Length
  • Quest Diagnostics, Inc.
  • Repeat Diagnostics Inc. (Repeat Dx)
  • Segterra, Inc.
  • SpectraCell Laboratories, Inc.
  • Telomere Diagnostics, Inc. (Tdx)
  • Zimetry LLC

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場の概要
  • 主要企業
  • 市場の動向と促進要因
  • 世界市場の見通し

第3章 市場の分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他の欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10955

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Cellular Health Testing Market to Reach $5.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Cellular Health Testing estimated at US$3 Billion in the year 2022, is projected to reach a revised size of US$5.8 Billion by 2030, growing at aCAGR of 8.6% over the period 2022-2030. Single-Test Panels, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Multi-Test Panels segment is readjusted to a revised 10.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $880.9 Million, While China is Forecast to Grow at 8.1% CAGR

The Cellular Health Testing market in the U.S. is estimated at US$880.9 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 8.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 7.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Select Competitors (Total 22 Featured):

  • Bio-Reference Laboratories, Inc.
  • Cell Science Systems Corp.
  • Cleveland Heartlab, Inc.
  • Dna Labs India
  • Genova Diagnostics
  • Immundiagnostik AG
  • Laboratory Corporation of America Holdings
  • Life Length
  • Quest Diagnostics, Inc.
  • Repeat Diagnostics Inc. (Repeat Dx)
  • Segterra, Inc.
  • SpectraCell Laboratories, Inc.
  • Telomere Diagnostics, Inc. (Tdx)
  • Zimetry LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Cellular Health Testing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Cellular Health Testing - Revolutionary Technology Provides Overview of Health at Cellular Level
    • North America Projected to Retain Maximum Share in the Market
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Accurate Telomere Length Test Steers Market Growth
    • Digital Transformation in Healthcare to Offer Significant Market Gains
    • Focus on Healthy Life Expectancy (HLE) as a Measure of Population Health Promise Growth Opportunities
    • Cellular Approach to Tackle Chronic Diseases Ensure Steady Growth Prospects
    • Continuous Rise in Geriatric Population Throws Focus on Cellular Heath Screening
    • Percentage (In %) of Global Population Aged 65 and Above by Region
    • US Population (In Million) Aged 65 and Above for the Years 2018, 2021, 2024, 2027, and 2030
    • Government Policies and Measures Promoting Preventative Healthcare Augurs Well
    • Personalized and Precision Medicine Presents Application Opportunities for Cellular Health Screening
    • Global Precision Medicine Market (In US$ Billion) for the Years 2019, 2021, 2023, 2025 & 2027
    • Growing Popularity of Direct-To-Consumer Approach to Testing Drives Market Demand
    • Key Challenges
    • Limited Reimbursement
    • Challenges in Sample Transportation
    • Variation in Pricing of Test Kits
    • Covid-19 Impact on Cellular Health Testing Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Single-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Multi-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Blood Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for At-home by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for In-office by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Cellular Health Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Sample Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Collection Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Collection Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Collection Sites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030
  • JAPAN
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030
  • CHINA
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: China 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: China 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030
  • EUROPE
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030
  • FRANCE
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: France 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: France 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: France 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030
  • GERMANY
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of World Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of World 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2023 & 2030
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2023 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2023 & 2030

IV. COMPETITION